Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Varian Outlines Plan For Proton Therapy Market – Interview

This article was originally published in The Gray Sheet

  • News

Executive Summary

Radiation oncology device manufacturer Varian Medical Systems signaled its plans to enter the nascent proton therapy field with the acquisition of equipment maker Accel Instruments early last year (1"The Gray Sheet" Jan. 8, 2007, p. 9)

You may also be interested in...



News In Brief

NuVasive buys Impulse Monitoring

News In Brief

NuVasive buys Impulse Monitoring

State Certificate Of Need Regulations May Warrant Revisiting

Hospitals should be free to make their own capital spending decisions rather than leave them to the fate of centralized government bodies, a recent study from Harvard economists suggests

Table

View full table

Related Content

Medtech Insight
Tags:
Latest Headlines

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win

See All
UsernamePublicRestriction

Register

MT026578

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By